HANNAH KINNEY: Open Payments
NPI 1912313404 · SYLVANIA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,239 in 68 payments from 14 companies in 2025. Trend: 2023 $1,099 · 2024 $1,286 · 2025 $1,239
Food & beverage: $1,239
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $374 |
| Ardelyx, Inc. | 10 | $231 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $190 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $108 |
| Intercept Pharmaceuticals, Inc. | 3 | $69 |
| Aimmune Therapeutics, Inc. | 3 | $60 |
| Janssen Biotech, Inc. | 3 | $58 |
| Organon LLC | 1 | $30 |
| Lilly USA, LLC | 1 | $27 |
| Novo Nordisk Inc | 1 | $23 |
Products named: IBSRELA, RINVOQ, EOHILIA, XIFAXAN, SKYRIZI, ENTYVIO, CREON, OCALIVA.
Industry payments across OH — which companies pay providers there.
